Startup Consulting & Venture Building:
Engagements & Capabilities

Client Archetype

A two-co-founder team (ex-operator + ex-engineer), 4 months out of corporate, working on a B2B SaaS thesis in workforce automation. Personal capital deployed; no external funding yet. Six months of customer interviews, no shipped product, no defined wedge.

The Situation

The founders had clear domain insight but were stuck on the gap between "we understand this space deeply" and "here is the specific wedge we will ship in 90 days." Specifically:

• ●Six months of customer discovery had produced 40 interview notes but no synthesised insight.
• ●Three candidate wedges sat side-by-side with no decision criteria for choosing between them.
• ●Buying-committee mapping was implicit, not documented.
• ●No defined first-customer-ICP for the MVP launch.
• ●No explicit answer to "why now" – the central question every pre-seed investor asks.

The Approach

A 6-week wedge-and-narrative engagement structured in three phases:

The Outcome

Engagements of this type typically deliver:

• ●Defensible wedge decision with documented rationale that investors can probe.
• ●First-customer ICP and 90-day MVP scope tied directly to commitment criteria.
• ●Equity story strong enough to anchor first institutional conversations.
• ●Founder confidence on "what to ship and what to ignore" for the next 90 days.
• ●Follow-on engagement clarity: MVP build, fundraising readiness, or both.

Client Archetype

A solo founder (clinical background, no prior software experience) with three signed letters of intent from clinics willing to pilot a workflow product. Needed an MVP shipped in 90 days that could survive real clinic deployment.

The Situation

The founder had product clarity from clinical experience but no technical co-founder, no engineering team, and no working software. Three pilot LOIs were time-bound. Specifically:

• ●Workflow logic existed only in the founder's head and a 30-page Notion doc.
• ●No defined data model, integration assumptions, or compliance posture.
• ●Clinic IT environments were unknown – no baseline understanding of EMR integration, network constraints, or device support.
• ●Pilot success criteria were vague ("the clinics like it") with no measurable acceptance gates.
• ●Founder needed to come out of the engagement with both a working product and the technical foundation to hire a CTO post-pilot.

The Approach

A 12-week build with explicit pilot-readiness gates, followed by 6 weeks of pilot support:

The Outcome

Engagements of this type typically deliver:

• ●Pilot-deployable MVP shipped in 12 weeks with documented architecture.
• ●Three reference customers running the product against measurable acceptance gates.
• ●Compliance posture established before deployment, not retrofitted.
• ●Technical foundation that supports a CTO hire – not throwaway code.
• ●Founder credibility lift for first institutional fundraise.

Client Archetype

A corporate partner with deep distribution in a specific vertical and a validated white-space thesis. Wanted to incubate a venture rather than build inside the corporate vehicle. Engaged NLabs to build, fund, and spin out a standalone company.

The Situation

The corporate had attempted internal incubation twice with mixed results – talent attraction, decision velocity, and equity alignment were the recurring blockers. They wanted an external studio to run the build with explicit spin-out economics. Specifically:

• ●No founder-in-residence yet – talent search was part of the engagement.
• ●Thesis was specific but had not been pressure-tested against real customers.
• ●Equity structure between corporate, studio, and incoming founder needed careful design.
• ●First external capital round would need to land within 12 months for the venture to be viable.

The Approach

A 9–12 month venture build structured in four phases:

The Outcome

Venture builds of this type typically deliver:

• ●Independent funded venture with founder-CEO and external capital within 12 months.
• ●Corporate retains strategic upside via equity stake without operating drag.
• ●Studio retains long-term economic alignment via co-ownership.
• ●Compounding studio capability across vertical theses and founder bench.

Post-Spin-Out

• ●Board observer role through Series A.
• ●On-call counsel for hiring, fundraising, and strategic decisions.
• ●Selective bench access for finance, GTM, and corridor-expansion needs.

Client Archetype

A bootstrapped founder operating profitably at ~SGD 800K ARR with 20% MoM growth, deciding to raise a seed round to compress time-to-Series-A. Strong product-market signal; no prior institutional fundraising experience.

The Situation

The founder had run the business well from a product and growth perspective but had no narrative, model, or data room suitable for institutional seed conversations. Specifically:

• ●Founder-deck was a customer pitch, not an investor pitch – no clear ask, valuation framing, or use of funds.
• ●Financial model was historical – no driver-based forecasting, no scenario analysis.
• ●Cohort and unit economics existed but had never been articulated in investor language.
• ●Fund landscape and partner mapping unknown to the founder.
• ●Cap table and SAFE notes from angel rounds had inconsistencies needing cleanup before diligence.

The Approach

An 8-week seed readiness engagement covering narrative, model, data room, and process:

The Outcome

Engagements of this type typically deliver:

• ●Investor-grade narrative, model, and data room ready before first partner meeting.
• ●Founder confident on institutional process choreography.
• ●Defensible valuation anchor informed by comparable seed transactions.
• ●Diligence cycle compression by virtue of preparation.
• ●We do not solicit investors or act as a placement agent – founder runs outreach.